Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,865 | 182 | 99.8% |
| Education | $6.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $545.67 | 47 | $0 (2020) |
| GlaxoSmithKline, LLC. | $385.11 | 19 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $257.64 | 17 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $242.29 | 16 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $203.16 | 12 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $189.39 | 12 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $167.74 | 9 | $0 (2020) |
| Allergan Inc. | $164.38 | 11 | $0 (2019) |
| Amgen Inc. | $93.14 | 4 | $0 (2022) |
| Lilly USA, LLC | $85.39 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $225.18 | 10 | GlaxoSmithKline, LLC. ($108.52) |
| 2022 | $60.55 | 3 | ABBVIE INC. ($45.72) |
| 2020 | $113.43 | 7 | Merck Sharp & Dohme Corporation ($28.99) |
| 2019 | $761.06 | 47 | PFIZER INC. ($146.52) |
| 2018 | $813.45 | 54 | PFIZER INC. ($261.41) |
| 2017 | $897.24 | 62 | Janssen Pharmaceuticals, Inc ($146.99) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Diabetes | ||||||
| 06/03/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 02/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes Care | ||||||
| 01/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: INSOMNIA | ||||||
| 11/30/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Inflammation | ||||||
| 03/05/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/28/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Neuroscience | ||||||
| 02/27/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/24/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/28/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/17/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/06/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/05/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: UROLOGY | ||||||
| 12/03/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,601 | 2,131 | $250,431 | $174,841 |
| 2022 | 23 | 1,678 | 2,139 | $233,399 | $168,088 |
| 2021 | 24 | 1,891 | 2,425 | $272,752 | $202,279 |
| 2020 | 28 | 1,924 | 2,346 | $235,726 | $173,301 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 387 | 591 | $85,695 | $52,281 | 61.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 199 | 199 | $29,850 | $26,628 | 89.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 200 | 204 | $16,220 | $14,575 | 89.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 146 | $19,418 | $14,070 | 72.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 74 | 88 | $20,240 | $12,514 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 130 | $14,300 | $7,521 | 52.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $7,575 | $7,053 | 93.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 210 | 214 | $6,420 | $6,292 | 98.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 77 | $7,007 | $4,948 | 70.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 27 | 27 | $5,130 | $4,616 | 90.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 53 | 67 | $6,834 | $4,447 | 65.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 47 | $5,217 | $4,090 | 78.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 26 | $5,200 | $3,492 | 67.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $4,030 | $2,980 | 73.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 17 | $3,825 | $2,876 | 75.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 14 | 18 | $3,420 | $2,681 | 78.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 35 | 36 | $3,240 | $1,386 | 42.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 30 | 30 | $900.00 | $882.00 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 56 | 58 | $2,900 | $626.60 | 21.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $770.00 | $423.18 | 55.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 40 | $1,600 | $340.46 | 21.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 17 | 26 | $312.00 | $83.46 | 26.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 41 | $328.00 | $35.24 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 366 | 581 | $84,245 | $55,194 | 65.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 226 | 226 | $33,900 | $31,271 | 92.2% |
About Dr. John Butler, MD
Dr. John Butler, MD is a Internal Medicine healthcare provider based in Meadowbrook, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629049606.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Butler, MD has received a total of $2,871 in payments from pharmaceutical and medical device companies, with $225.18 received in 2023. These payments were reported across 183 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,865).
As a Medicare-enrolled provider, Butler has provided services to 7,094 Medicare beneficiaries, totaling 9,041 services with total Medicare billing of $718,510. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Meadowbrook, PA
- Active Since 01/30/2006
- Last Updated 03/25/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629049606
Products in Payments
- CHANTIX (Drug) $345.59
- XARELTO (Drug) $242.29
- TRELEGY ELLIPTA (Drug) $234.89
- JANUVIA (Drug) $198.46
- FARXIGA (Drug) $172.59
- ENTRESTO (Drug) $167.74
- JARDIANCE (Drug) $128.08
- ANORO (Drug) $105.80
- LYRICA (Drug) $85.08
- LINZESS (Drug) $72.13
- Livalo (Drug) $68.47
- TRULICITY (Drug) $54.89
- SPIRIVA RESPIMAT (Drug) $54.76
- Aimovig (Biological) $52.60
- NAMZARIC (Drug) $50.51
- QULIPTA (Drug) $45.72
- ADVAIR (Drug) $44.42
- VIAGRA (Drug) $42.08
- Vascepa (Drug) $41.33
- UBRELVY (Drug) $39.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Meadowbrook
David Litt, Md, MD
Internal Medicine — Payments: $3,821
Dominick Galluzzo, Md, MD
Internal Medicine — Payments: $2,072
Dr. Leonard Khrizman, M.d, M.D
Internal Medicine — Payments: $551.55
Joseph Viknevich, M.d, M.D
Internal Medicine — Payments: $453.22
Dr. Babak Pirouz, Md, MD
Internal Medicine — Payments: $314.45
Maureen Armstrong, Do, DO
Internal Medicine — Payments: $121.36